Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Angiotensins structure-activity

Mayer, D., Naylor, C.B., Motoc, I., Marshall, G.R. Aunique geometry of the active site of angiotensin-converting enzyme consistent with structure-activity studies./. Comput.-Aided Mol. Des. 1987, 3(1), 3-16. [Pg.20]

Yanagisawa H, Amemiya Y, Kanazaki T, Shimoji Y, Fujimoto K, Kitahara Y, Sada T, Mizuno M, Ikeda M, et al. Nonpeptide angiotensin II receptor a ntago-nists synthesis, biological activities, and structure-activity relationships ofimi-dazole-5-carboxylic acids bearing alkyl, alkenyl, and hydroxyalkyl substituents at the 4-position and their related compounds./. Med. Chem., 1996, 39, 323-338. [Pg.51]

Waller, C.L. and Marshall, G.R. (1993) Three-dimensional quantitative structure-activity relationship of angiotensin converting enzyme and thermolysin inhibitors. 2. A comparison of CoMFA models incorporating molecular orbital fields and desolvation free energies based on active analog and complementary receptor field alignment rules. J. Med. Chem., 36, 2390-2403. [Pg.1195]

Wu, J. and Aluko, R.E. (2007) Quantitative structure-activity relationship study of bitter di- and tripeptides including relationship with angiotensin I-converting enzyme inhibitory activity./. Pestic. Sci., 13, 63-69. [Pg.1201]

N. Rankine, J. M. Revill, D. A. Roberts, and S. T. Russell, /. Med. Chem., 35,4027 (1992). New Nonpeptide Angiotensin II Receptor Antagonists. 2. Synthesis, Biological Properties, and Structure-Activity Relationships of 2-Alkyl-4-(biphenylylmethoxy)quinoline Derivatives. P. Biihlmayer, L. Criscione, W. Fuhrer, P. Furet, M. de Gasparo, S. Stutz, and... [Pg.371]

A Unique Geometry of the Active Site of Angiotensin-Converting Enzyme Consistent with Structure—Activity Studies. [Pg.377]

Novel ATj-selective angiotensin II receptor antagonists (111) have been prepared and structure-activity relationships in this series have been established [93MI(3)2023]. 6-(l -Imidazol-l-yl)-7-nitro-2,3(l/f,4//)-quinoxalinedione hydrochloride (YM90K) and related compounds 112 have been nthesised as novel antiepileptic agents (94JMC(37)4671. [Pg.239]

D. Mayer, C. B. Naylor, 1. Motoc, and G. R. Marshall,/. Comput.-Aided Mol. Design, 1,3 (1987). A Unique Geometry of the Active Site of Angiotensin-Converting Enzyme Consistent with Structure Activity Studies. [Pg.115]

A.R De Arriba, L.A. Gomez-Casajus, F. Cavalcanti, C. Almansa, J. Garcia-Rafanell, J. Fore, Synthesis and structure-activity relationship of a new series of potent ATj selective angiotensin II receptor antagonists 5-(biphenyl-4-yhnethyl)pyrazoles, J. Med. Chem. 40 (1997) 547-548. [Pg.487]

All = angiotensin II APA = anilinophenylacetamide 3D = three-dimensional MMFF = Merck macromolecular force field SAR = structure-activity relationship SPERM superposition by permutation. [Pg.1693]

Angiotensin 11 the potent vasoconstrictor and pressor octapeptlde released from a plasma a2-globulln by the kidney enzyme, renin, continues to receive considerable research attention. A comprehensive review of the chemistry, structure-activity relationships and biology of the renin-angiotensin system has just become available. The structure of human angiotensin II was reported to be identical to that of horse (lie in position 5 rather than V il for bovine). Several radioimmunoassays have been reported ... [Pg.195]


See other pages where Angiotensins structure-activity is mentioned: [Pg.191]    [Pg.28]    [Pg.710]    [Pg.274]    [Pg.586]    [Pg.593]    [Pg.261]    [Pg.80]    [Pg.136]    [Pg.28]    [Pg.63]    [Pg.569]    [Pg.82]    [Pg.160]    [Pg.950]    [Pg.1117]    [Pg.52]    [Pg.258]    [Pg.620]    [Pg.71]    [Pg.569]    [Pg.145]    [Pg.215]    [Pg.292]    [Pg.450]    [Pg.96]    [Pg.7]    [Pg.148]    [Pg.142]    [Pg.227]    [Pg.379]    [Pg.449]    [Pg.128]    [Pg.36]   


SEARCH



Angiotensin, structure

© 2024 chempedia.info